← Back to Clinical Trials
Recruiting NCT07677527

NCT07677527 Efficacy of Vicarious Post-Traumatic Growth Intervention for Nurses in Emergency Units

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07677527
Status Recruiting
Phase
Sponsor Fatima Jinnah Women University
Condition Vicarious Trauma
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-03-01
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Psychoeducational Vicarious Post-Traumatic Growth Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-03-01 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial aims to evaluate the efficacy of a Vicarious Post-Traumatic Growth (VPTG) Intervention among nurses working in emergency units. Emergency nurses are frequently exposed to traumatic events through patient care, which may contribute to vicarious trauma and psychological distress. The intervention is designed to facilitate positive psychological growth, resilience, adaptive coping, and psychological well-being while reducing the adverse impact of indirect trauma exposure. Participants will be randomly assigned to intervention and control groups. Outcomes will be assessed at baseline, post-intervention, and follow-up periods to determine the effectiveness of the intervention in promoting vicarious post-traumatic growth and reducing vicarious trauma among emergency nurses.

Eligibility Criteria

Inclusion Criteria: 1. Registered nurses currently employed in emergency departments. 2. Minimum six months of emergency department work experience. 3. Able to read and understand English or Urdu. 4. Willing to provide informed consent. 5. Available to participate throughout intervention and follow-up assessments. Exclusion Criteria: 1. Current diagnosis of severe psychiatric disorder requiring intensive treatment. 2. Current participation in trauma-focused psychotherapy. 3. Cognitive impairment affecting study participation. 4. Planned transfer from emergency unit during study period. 5. Refusal to provide informed consent.

Contact & Investigator

Central Contact

SEERAT FATIMA

✉ seeratfatima554@gmail.com

📞 +923066605577

Frequently Asked Questions

Who can join the NCT07677527 clinical trial?

This trial is open to participants of all sexes, studying Vicarious Trauma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07677527 currently recruiting?

Yes, NCT07677527 is actively recruiting participants. Contact the research team at seeratfatima554@gmail.com for enrollment information.

Where is the NCT07677527 trial being conducted?

This trial is being conducted at Multan, Pakistan.

Who is sponsoring the NCT07677527 clinical trial?

NCT07677527 is sponsored by Fatima Jinnah Women University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology